Clinical Trials Directory

Trials / Unknown

UnknownNCT05504382

Effect of Electroacupuncture on Refractory Pain in Juvenile Rheumatoid Arthritis: Randomized Controlled Trial

Effect of Electroacupuncture Versus Phonophoresis on Refractory Pain in Juvenile Rheumatoid Arthritis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
42 (estimated)
Sponsor
Mohamed Abdelmoneim El Meligy · Academic / Other
Sex
All
Age
14 Years – 16 Years
Healthy volunteers
Not accepted

Summary

the purpose of the study is to investigate the effect of Electrical Acupuncture Versus naproxen phonophoresis on Refractory pain in Juvenile Rheumatoid arthritis

Detailed description

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and adolescents, affecting approximately one in 1000 children in North America. It is diagnosed in children younger than 16 years of age with arthritis in one or more joints for at least six weeks after other causes have been excluded. Arthritis in JIA is characterized by stiffness, pain and swelling of affected joints. The disease course of JIA may involve flares of increased disease activity or chronic persistent joint inflammation, even into adulthood. Various complications may arise secondary to ongoing disease activity or treatment, including joint damage and deformity, growth abnormalities and osteoporosis with fragility fractures The prevalence of refractory pain in children with arthritis is of particular concern because it often contributes to poor physical and psychosocial outcomes. Increased daily symptoms of pain predict considerable functional disability, including significantly reduced participation in school, social and physical activities, and augmented mood disturbance

Conditions

Interventions

TypeNameDescription
DEVICEnaproxen phonophoresistransmission of naproxen molecule by therapeutic ultrasound

Timeline

Start date
2022-08-01
Primary completion
2022-11-01
Completion
2023-05-01
First posted
2022-08-17
Last updated
2022-08-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05504382. Inclusion in this directory is not an endorsement.